Skip to content
Home/Companies/Healthcare/VaccinDirekt

VaccinDirekt

Healthcare·Sweden·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns VaccinDirekt?

VaccinDirekt is a Swedish Healthcare company, currently owned by Impilo since 2023.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQSweden
SectorHealthcare
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Decon
Active
MedTechSweden· 2023
Pelago Bioscience
Active
PharmaSweden· 2023
Stille
Active
MedTechSweden· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns VaccinDirekt?

VaccinDirekt is currently owned by Impilo, through Impilo Investment Pool 2, since 2023.

When did Impilo acquire VaccinDirekt?

Impilo acquired VaccinDirekt in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue